Perfluoroalkyl substances (PFAS) are highly persistent chemicals that
might be associated with asthma and allergy, but the associations remain
unclear. Therefore, this study examined whether pre- and post-natal PFAS
exposure was associated with childhood asthma and allergy. Measles, mumps and
rubella (MMR) vaccination in early life may have a protective effect against
asthma and allergy and is therefore taken into account when evaluating these
associations. In a cohort of Faroese children whose mothers were recruited
during pregnancy, serum concentrations of five PFAS were measured:
Perfluorohexane sulfonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS),
perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), and
perfluorodecanoic acid (PFDA) at three timepoints (maternal serum in pregnancy
week 34–36 and child serum at ages 5 and 13 years) and determined their
association with immunoglobulin E (IgE) (cord blood and at age 7 years) and
asthma/allergic diseases (questionnaires at ages 5 and 13 years and skin prick
test at age 13 years). A total of 559 children were included in the analyses.
Interactions with MMR vaccination were evaluated. Among 22 MMR-unvaccinated
children, higher levels of the five PFAS at age 5 years were associated with
increased odds of asthma at ages 5 and 13. The associations were reversed among
MMR-vaccinated children. Pre-natal PFAS exposure was not associated with
childhood asthma or allergic diseases regardless of MMR vaccination status. In
conclusion, PFAS exposure at age 5 was associated with increased risk of asthma
among a small subgroup of MMR-unvaccinated children but not among MMR-vaccinated
children. While PFAS exposure may impact immune system functions, this study
suggests that MMR vaccination might be a potential effect-modifier.